Top compounds associated with response to TAF1D


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA austocystin d CTRPv2 pan-cancer AAC -0.084 0.03
mRNA UNC0638 CTRPv2 pan-cancer AAC -0.081 0.03
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.071 0.03
mRNA AS601245 GDSC1000 pan-cancer AAC 0.078 0.03
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.077 0.03
mRNA Crizotinib gCSI pan-cancer AAC 0.14 0.03
Download CSV